Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
38 /100
MEDIUM RISK
Score updated Sep 12, 2026

UPB — Upstream Bio, Inc. Dilution Risk Tracker

Track UPB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track UPB — Get alerts when the score changes →

As of September 12, 2026, Upstream Bio, Inc. (UPB) has a DilutionWatch DilutionScore of 38/100, rated MEDIUM dilution risk. Upstream Bio, Inc. has a market capitalization of $454.95M, 54.77M shares outstanding, 144 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 20%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 22% potential dilution
• Elevated convertible risk (60/100)
🔔 Track UPB — Get forecast alerts →

Market Data

Market Cap$454.95M
Shares Outstanding54.77M
Float34.97M
Cash$261.31M
Debt$1.11M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore38/100DilutionWatch score record
Shares Outstanding54.77MVerified float table or market cache
Public Float34.97MVerified float table or market cache
Market Cap$454.95MMarket data cache
Cash Runway23.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 3.9% shares (2026Q1 vs prior)
144 institutional holders · 49.40M shares
#1 FMR LLC 8.10M shares
#2 ORBIMED ADVISORS LLC 5.69M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.75M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.10M
Days to Cover7.5
% of Float11.7%
FINRA data as of Aug 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-09-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual UPB Dilution Snapshot

Upstream Bio, Inc. (UPB) has a DilutionScore of 38/100, rated Medium dilution risk. Score date: September 12, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track UPB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking UPB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,348+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for UPB
UPB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.